United Therapeutics Overview
United Therapeutics Target Price
Analysts' 12-month price predictions for UTHR.
Share Price
$369.67
Average Target Price
$458.00
23.9% upside
23.9% upside4 analysts in the last 4 months
High: $575 | Low: $400
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-10-31 | Argus ResearchJasper Hellweg | $400 | 8.2% upside |  |
| 2024-10-31 | H.C. WainwrightAndrew Fein | $425 | 15% upside | |
| 2024-09-23 | JefferiesEun Yang | $432 | 16.9% upside | |
| 2024-08-28 | OppenheimerHartaj Singh | $575 | 55.5% upside | |
| 2024-07-08 | UBSAshwani Verma | $370 | 0.1% upside | |
| 2024-06-12 | Wells FargoTiago Fauth | $350 |  5.3% downside | |
| 2024-05-02 | OppenheimerHartaj Singh | $400 | 8.2% upside | |
| 2024-02-12 | Goldman SachsChris Shibutani | $215 | 41.8% downside | |
| 2023-01-11 | Argus Research | $300 | 18.8% downside | |
| 2022-12-06 | Morgan Stanley | $330 | 10.7% downside | |
| 2022-12-06 | UBS | $320 | 13.4% downside | |
| 2022-12-05 | Goldman Sachs | $230 | 37.8% downside | |
| 2022-05-24 | J.P. Morgan | $238 | 35.6% downside | |
| 2022-05-24 | Jefferies | $245 | 33.7% downside | |
| 2022-05-24 | Credit Suisse | $247 | 33.2% downside | |
| 2022-05-24 | H.C. Wainwright | $255 | 31% downside | |
| 2022-04-19 | J.P. Morgan | $223 | 39.7% downside | |
| 2021-05-05 | Credit SuisseTiago Fauth | $205 | 44.5% downside | |